Community-based treatment of advanced HIV disease: Introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy)

Bulletin of the World Health Organization

Volumn 79, Issue 12, 2001, Pages 1145-1151

  Farmer, Paul ^a,b   Léandre, Fernet ^c   Mukherjee, Joia ^a,b   Gupta, Rajesh ^a   Tarter, Laura ^a   Kim, Jim Yong ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Zanmi Lasante ^*

^c Zanmi Lasante   (Haïti)

Author keywords

Acquired immunodeficiency syndrome drug therapy; Community health services; Drug costs; Haiti (source: MeSH); Highly active antiretroviral therapy economics; HIV infections drug therapy; Poverty; Tuberculosis, Multidrug resistant drug therapy

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COMMUNITY CARE; DISEASE CONTROL; HUMAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COMMUNITY CARE; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG COST; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PUBLIC HEALTH; TREATMENT PLANNING; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; COMMUNITY HEALTH SERVICES; DEVELOPING COUNTRIES; DIRECTLY OBSERVED THERAPY; DRUG COSTS; HAITI; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); POVERTY; PUBLIC HEALTH PRACTICE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0035700787     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Factors impacting on drug choices. Issues for developing countries
2. AIDS meeting. Companies, donors pledge to close gap in AIDS treatment
3. Consensus statement on antiretrovial treatment for AIDS in poor countries
4. Global AIDS epidemic: Time to turn the tide
5. Something to be done: Treating HIV/AIDS
6. The changing face of AIDS: Implications for policy and practice
7. Tuberculosis control in Sudan against seemingly insurmountable odds
8. HPV-related neoplasias in HIV-infected individuals
9. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children
10. A nation in pain: Why the HIV/AIDS epidemic is out of control in Zimbabwe
11. Admission trends in a rural South African hospital during the early years of the HIV epidemic
12. Empirical evidence for the severe but localized impact of AIDS on population structure
13. Social inequalities and emerging infectious diseases
14. Impact of insecurity, the AIDS epidemic, and poverty on population health: Disease patterns and trends in Northern Uganda
15. HIV and AIDS, poverty, and causation
16. Debt and poverty turn a disease into an epidemic
17. Child prostitution and the spread of AIDS
18. Burma and Cambodia: Human rights, social disruption, and the spread of HIV/AIDS
19. Structural factors affecting women's HIV risk: A life-course example
20. Achievable standard of care in low-resource settings
21. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa
22. Global dimensions of the AIDS epidemic: Implications for prevention and care
23. Organizational approaches to the HIV/AIDS crisis
24. Predictors of AIDS knowledge, condom use and high risk sexual behaviour among women in Dar-es-Salaam, Tanzania
25. AIDS-related knowledge and risks and contraceptive practices in Ghana: The early 1990s
26. Advances in control of sexually transmitted disease in developing countries
27. Defining and refining international donor support for combating the AIDS pandemic
28. Policy on AIDS in Africa debated, leaders say prevention should be the focus
29. Rich nations consider fund of billions to fight AIDS
30. Impact of new developments in antiretroviral treatment on AIDS prevention and care in resource-poor countries
31. Tuberculosis control in resource-poor settings with high rates of HIV infection
32. AIDS in Haiti: 1982-1992
33. DOTS and drug resistance: A silver lining to a darkening cloud
34. Letter from Haiti
35. Community-based approaches to HIV treatment in resource-poor settings
36. Condoms, coups, and the ideology of prevention: Facing failure in rural Haiti
37. Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: A population-based prospective study of 301 pulmonary tuberculosis patients
38. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
39. Psychosocial and economic aspects of HIV/AIDS and counselling of caretakers of HIV-infected children in Uganda
40. Selling cheap 'generic' drugs, India's copycats irk industry
41. An unusual calculus of life and death; as millions perished in pandemic, firms debated access to drugs; players in the debate over drug availability and pricing
42. The cost effectiveness of combination antiretroviral therapy for HIV disease
43. Rifampicin or ethambutol in the routine treatment of tuberculosis
44. Responding to market failures in tuberculosis control
45. The major infectious diseases in the world - To treat or not to treat?